CAROSATI, Emanuele
 Distribuzione geografica
Continente #
NA - Nord America 1.044
EU - Europa 985
AS - Asia 378
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.413
Nazione #
US - Stati Uniti d'America 1.038
UA - Ucraina 211
SE - Svezia 197
IE - Irlanda 194
VN - Vietnam 176
IT - Italia 174
HK - Hong Kong 133
DE - Germania 50
FI - Finlandia 50
RU - Federazione Russa 42
CN - Cina 34
GB - Regno Unito 28
TR - Turchia 15
FR - Francia 9
CA - Canada 6
CH - Svizzera 6
AT - Austria 5
BE - Belgio 5
GR - Grecia 4
IR - Iran 4
NL - Olanda 4
UZ - Uzbekistan 4
PL - Polonia 3
SG - Singapore 3
CI - Costa d'Avorio 2
CL - Cile 2
EU - Europa 2
IN - India 2
JP - Giappone 2
LB - Libano 2
RO - Romania 2
CZ - Repubblica Ceca 1
IQ - Iraq 1
KR - Corea 1
MY - Malesia 1
Totale 2.413
Città #
Chandler 264
Dublin 194
Dong Ket 172
Hong Kong 132
Jacksonville 100
San Mateo 100
Perugia 73
Altamura 49
Medford 47
Princeton 47
Wilmington 42
Lawrence 38
Andover 32
Ann Arbor 28
Beijing 28
Boardman 17
Fremont 16
Des Moines 15
Izmir 15
Città Di Castello 11
Saint Petersburg 11
Philadelphia 9
Ashburn 8
Falls Church 8
San Diego 7
Helsinki 6
Brussels 5
Mcallen 5
New York 5
Ottawa 5
Arak 4
Hanoi 4
Norwalk 4
Alameda 3
Auburn Hills 3
Moscow 3
San Paolo di Civitate 3
Tappahannock 3
Woodbridge 3
Abidjan 2
Athis-Mons 2
Bologna 2
Chicago 2
Den Haag 2
Florence 2
Guangdong 2
Laurel 2
Lausanne 2
Messina 2
Milan 2
Olgiate Olona 2
Pedrengo 2
Redmond 2
Timisoara 2
Tokyo 2
Verona 2
Aurisina 1
Blue Bell 1
Clearwater 1
Corciano 1
Düsseldorf 1
Essen 1
Fort Worth 1
Frankfurt am Main 1
Genova 1
Halle 1
Las Vegas 1
Latina 1
Nanning 1
Narni 1
Redwood City 1
Santa Clara 1
Santa Maria Di Sala 1
Santiago 1
Simi Valley 1
Singapore 1
Totale 1.573
Nome #
1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far And Perspectives (Part 2): Action in Other Targets and Antitargets 187
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs 172
Discovery of Novel and Cardioselective Diltiazem-like Calcium Channel Blockers via Virtual Screening 88
Inhibitor of Ovarian Cancer Cells Growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 77
Calcium channel antagonists discovered by a multidisciplinary approach 71
MetaSite: Understanding Metabolism in Human Cytochromes from the Perspective of the Chemist 70
Stereoselective Behavior of the Functional Diltiazem Analogue 1-[(4-Chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a New L-Type Calcium Channel Blocker 64
Absolute configuration and biological profile of two thiazinooxadiazol-3-ones with L-type calcium channel activity: a study of the structural effects 64
Use of a Combined GLUE/ALMOND Approach in QSAR-Studies on (aryl) Bridged 2-Aminobenzonitriles Inhibiting HIV-1 Reverse Transcriptase 63
Hydrogen Bonding Interactions of Covalently-Bonded Fluorine Atoms: From Crystallographic Data to a New Angular Function in the GRID Force Field 63
Transporter-Mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target 61
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 56
Recent improvement in the GRID Force Field. 1. The docking Procedure GLUE 56
The flavonoid scaffold as a template for the design of modulators of the vascular Ca(v)1.2 channels 56
QSAR Modeling and Data Mining Link Torsades de Pointes Risk to the Interplay of Extent of Metabolism, Active Transport, and hERG Liability 55
Integrating Crystallography into Early Metabolism Studies 54
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 54
ADME-Space: A new tool for medicinal chemists to explore ADME properties 54
Discovery of Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus. 51
Homodimeric enzymes as drug targets 50
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 50
Ligand Promiscuity between the Efflux Pumps Human P-Glycoprotein and S. aureus NorA 50
Characterization of Protein-Binding Sites and Ligands Using Molecular Interaction Fields 49
FLAP: GRID Molecular Interaction Fields in Virtual Screening. Validation using the DUD Data Set 49
Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors 47
MetaSite: understanding CYP antitarget modelling for early toxicity detection 46
Ligands of Diltiazem Binding Site: An Overview of Some Chemotypes 45
A new class of selective myocardial calcium channel modulators. 2. Role of the acetal chain in oxadiazol-3-one derivatives. 44
Peptide studies by means of principal properties of amino acids derived from MIF descriptors 43
Large, chemically diverse dataset of log P measurements for benchmarking studies 43
Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists 43
L-Type Calcium Channel Blockers: From Diltiazem to 1,2,4-Oxadiazol-5-ones via Thiazinooxadiazol-3-one Derivatives 41
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-Dioxide: A Promising New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors 38
VolSurf: a tool for drug ADME-properties prediction 37
Recent improvement in the GRID Force Field. 2. A new Angular Function Derived from Crystallographic Data for describing Hydrogen Bonding Interactions of Covalenty-Bonded Fluorine Atoms 37
Novel apoptosis inducers overcome IAP-mediated resistance of the renal cell carcinoma cell line ClearCa-2 37
A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields 37
IAP antagonists: promising candidates for cancer therapy 36
Discovery of Novel, Potent, and Specific Cell-Death Inducers in the Jurkat Acute Lymphoblastic Leukemia Cell Line 36
The Complexity of Molecular Interaction: Molecular Shape Fingerprints by the PathFinder Approach 35
Use of MIF-based VolSurf Descriptors in Physicochemical and Pharmacokinetic Studies 33
On the catalytic role of the active site residue E121 of E. coli L-aspartate oxidase 32
Targeting Cystalysin, a Virulence Factor of Treponema denticola-Supported Periodontitis 29
Three-Dimensional Quantitative Structure-Properties Relationships 28
Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity 26
Nuove molecole per uso come agenti antitumorali 25
Novel apoptosis inducers in the acute lymphatic leukemia cell line JM 21
Totale 2.503
Categoria #
all - tutte 8.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 0 0 0 23 1
2019/2020197 2 2 25 3 24 5 36 9 37 30 4 20
2020/2021569 1 34 23 32 119 40 27 2 50 21 34 186
2021/2022425 12 67 11 34 29 7 2 136 8 4 60 55
2022/2023755 49 141 13 76 65 86 0 33 261 1 23 7
2023/2024245 24 37 14 8 8 1 44 1 103 5 0 0
Totale 2.503